# Study of GC101 TIL in Brain Glioma (Soochow2)

> **NCT04943913** · EARLY_PHASE1 · RECRUITING · sponsor: **Shanghai Juncell Therapeutics** · enrollment: 50 (estimated)

## Conditions studied

- Glioma

## Interventions

- **BIOLOGICAL:** Tumor Infiltrating Lymphocytes (TIL)

## Key facts

- **NCT ID:** NCT04943913
- **Lead sponsor:** Shanghai Juncell Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-06
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-05-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04943913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04943913, "Study of GC101 TIL in Brain Glioma (Soochow2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04943913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*